[Federal Register: September 21, 2000 (Volume 65, Number 184)]
[Notices]
[Page 57189-57190]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21se00-69]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
White House Commission on Complementary and Alternative Medicine
Policy; Notice of Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the
White House Commission on Complementary and Alternative Medicine
Policy. The purpose of the meeting is to convene the Commission for a
public hearing on coordinated Research and Development activities
relating to complementary and alternative medicine practices and
products, and to receive public testimony from individuals and
organizations interested in the subject of federal policy regarding
complementary and alternative medicine. Comments received at the
meeting may be used by the Commission to prepare the Report to the
President as required by the Executive Order.
Comments should focus on Coordinated Research and Development
Activities To Increase Knowledge of Complementary and Alternative
Medicine Practices and Interventions. Issues to be discussed include
the following: Research Priorities and Public Input; Federal, Private
Sector, and Not-for-Profit Sector Support for CAM Research;
Facilitating CAM Research and Regulatory Challenges; Practice-based
Research and Outcomes Research. Discussion also may focus on the
following questions:
(1) What can be done to expand the current research environment so
that practices and interventions that lie outside conventional science
are adequately and appropriately addressed?
(2) What types of incentives are needed to stimulate the research
of CAM practices and interventions by the public and private sectors?
(3) How can we more effectively integrate the CAM and conventional
research communities to stimulate and coordinate research?
Some Commission members may participate by telephone conference.
The meeting is open to the public and opportunities for oral statements
by the public will be provided on October 5, from about 1:15 p.m.-2:15
p.m.; and on October 6, from about 2:40 p.m.-3:40 p.m. (approximate
times).
Name of Committee: White House Commission on Complementary and
Alternative Medicine Policy.
Date: October 5-6, 2000.
Time: October 5-8:30 a.m.-5:30 p.m.; October 6-8:30 a.m.-4 p.m.
[[Page 57190]]
Place: Hubert H. Humphrey Building, Room 800, 200 Independence
Avenue, S.W., Washington, DC 20201.
Contact Persons: Michele M. Chang, CMT, MPH, Executive Secretary OR
Stephen C. Groft, Pharm. D., Executive Director, 6701 Rockledge Drive,
Room 1010, MSC 7707, Bethesda, MD 20817-7707, Phone: (301) 435-7592,
Fax: (301) 480-1691, E-mail: WHCCAMP@nih.gov.
Because of the need to obtain the views of the public on these
issues as soon as possible and because of the early deadline for the
report required of the Commission, this notice is being provided at the
earliest possible time.
SUPPLEMENTARY INFORMATION: The President established the White House
Commission on Complementary and Alternative Medicine Policy on March 7,
2000 by Executive Order 13147. The mission of the White House
Commission on Complementary and Alternative Medicine Policy is to
provide a report, through the Secretary of the Department of Health and
Human Services, on legislative and administrative recommendations for
assuring that public policy maximizes the benefits of complementary and
alternative medicine to Americans.
Public Participation
The meeting is open to the public with attendance limited by the
availability of space on a first come, first serve basis. Members of
the public who wish to present oral comments may register by calling 1-
800-953-3298 or by accessing https://safe2.sba.com/whccamp/index.cfm no
later than September 29, 2000.
Oral comments will be limited to five minutes. Individuals who
register to speak will be assigned in the order in which they
registered. Due to time constraints, only one representative from each
organization will be allotted time for oral testimony. The number of
speakers and the time allotted may also be limited by the number of
registrants. All requests to register should include the name, address,
telephone number, and business or professional affiliation of the
interested party, and should indicate the area of interest or question
(as described above) to be addressed.
Any person attending the meeting who has not registered to speak in
advance of the meeting will be allowed to make a brief oral statement
during the time set aside for public comment if time permits, and at
the chairperson's discretion. Individuals unable to attend the meeting,
or any interested parties, may send written comments by mail, fax, or
electronically to the staff office of the Commission for inclusion in
the public record.
When mailing or faxing written comments provide, if possible, an
electronic version on diskette. Persons needing special assistance,
such as sign language interpretation or other special accommodations,
should contact the Commission staff at the address or telephone number
listed no later than September 29, 2000.
Dated: September 12, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committe Policy.
[FR Doc. 00-24232 Filed 9-20-00; 8:45 am]
BILLING CODE 4140-01-M